[ad_1]
The new figures reinforce the image that the Pfizer-Biontech vaccine is an effective protection against the spread of COVID-19. Less than a week ago, the results of a study involving 600,000 people in Israel who received both injections of the vaccine were published.
That study showed that the vaccine against covid-19, the number of symptomatic patients decreased by 94 percent. Earlier this week, the Israeli health organization Maccabi published figures of 620,000 people who had then received their second dose. These showed that the vaccine had 95% protection against the virus. Only 608 infected people were found.
On Saturday, the Israeli Health Ministry confirmed that Pfizer’s vaccine reduced the number of people infected with the virus by 95.8 percent among those who had received both injections. This compared to people who have not been vaccinated at all, writes the Israeli newspaper Haaretz.
The information is based on a sample of the 3.5 million people who then received both doses.
The vaccine is also 98 percent effective in reducing severe coronary disease, such as fever and shortness of breath, and 98.9 percent effective in preventing the patient from being hospitalized or dying as a result of the infection. Write the Jerusalem Post.
Information has been collected through February 13 from people who received their second injection at least two weeks earlier.
“The vaccine clearly reduces mortality and we can see that effect in the data that we have on deaths in the country,” Israel Health Ministry Director General Chezy Levy told the Jerusalem Post.
Israel’s vaccination program, which has so far reached the largest number of people compared to the world’s population, has meant that several restrictions have now been relaxed and authorities will reopen schools for 1.2 million students and many stores, gyms and shopping centers on Sunday .
The authorities have also created an application with a “Green Passport” that those who have received their two syringes or have been judged immune after suffering the disease can show when they want to stay in hotels or participate in various cultural events. The app is linked to the person’s medical records, writes the Reuters news agency.
But the application has already suffered problems, less than 24 hours after its launch, writes the Hayom newspaper. According to the newspaper, the system became overloaded when millions of Israelis simultaneously tried to enter the application to start using it.
Israel began vaccination on December 19.
